LOXL2 and lip and oral cavity carcinoma: Although complete inhibition of cancer growth was not accomplished, the possibility is raised that LOXL2 inhibitors in combination with other therapeutic approaches including immunotherapy could result in potentially effective strategies to address oral cancer.